- Home
- FLY vs TECH Comparison
FLY vs TECH Comparison
Compare FLY & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLY
- TECH
- Stock Information
- Founded
- FLY 2017
- TECH 1976
- Country
- FLY United States
- TECH United States
- Employees
- FLY N/A
- TECH N/A
- Industry
- FLY Military/Government/Technical
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLY Industrials
- TECH Health Care
- Exchange
- FLY Nasdaq
- TECH Nasdaq
- Market Cap
- FLY 7.1B
- TECH 7.8B
- IPO Year
- FLY 2025
- TECH 1989
- Fundamental
- Price
- FLY $44.19
- TECH $53.42
- Analyst Decision
- FLY Buy
- TECH Buy
- Analyst Count
- FLY 6
- TECH 12
- Target Price
- FLY $55.17
- TECH $69.82
- AVG Volume (30 Days)
- FLY 3.2M
- TECH 2.2M
- Earning Date
- FLY 05-13-2021
- TECH 10-29-2025
- Dividend Yield
- FLY N/A
- TECH 0.60%
- EPS Growth
- FLY N/A
- TECH N/A
- EPS
- FLY N/A
- TECH 0.46
- Revenue
- FLY $108,330,000.00
- TECH $1,219,635,000.00
- Revenue This Year
- FLY N/A
- TECH $4.13
- Revenue Next Year
- FLY N/A
- TECH $7.56
- P/E Ratio
- FLY N/A
- TECH $115.96
- Revenue Growth
- FLY 10.06
- TECH 5.23
- 52 Week Low
- FLY $43.61
- TECH $46.01
- 52 Week High
- FLY $73.80
- TECH $80.95
- Technical
- Relative Strength Index (RSI)
- FLY N/A
- TECH 46.80
- Support Level
- FLY N/A
- TECH $52.93
- Resistance Level
- FLY N/A
- TECH $57.60
- Average True Range (ATR)
- FLY 0.00
- TECH 1.61
- MACD
- FLY 0.00
- TECH -0.07
- Stochastic Oscillator
- FLY 0.00
- TECH 20.98
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.